4//SEC Filing
Bronfeld Zeev 4
Accession 0001104659-20-011315
CIK 0001006281other
Filed
Feb 4, 7:00 PM ET
Accepted
Feb 5, 5:01 PM ET
Size
10.6 KB
Accession
0001104659-20-011315
Insider Transaction Report
Form 4
Bronfeld Zeev
Director10% Owner
Transactions
- Award
Stock Options (Right to Buy)
2020-02-03+240,000→ 240,000 totalExercise: $3.70Exp: 2030-02-03→ Common Stock (240,000 underlying)
Footnotes (1)
- [F1]The shares of common stock underlying the stock options shall vest in 16 equal quarterly installments commencing upon the date of grant. The stock options are subject to accelerated vesting upon a corporate transaction or a change in control as described in the Protalix BioTherapeutics, Inc., 2006 Stock Incentive Plan, as amended.
Issuer
Protalix BioTherapeutics, Inc.
CIK 0001006281
Entity typeother
Related Parties
1- filerCIK 0001298522
Filing Metadata
- Form type
- 4
- Filed
- Feb 4, 7:00 PM ET
- Accepted
- Feb 5, 5:01 PM ET
- Size
- 10.6 KB